设为首页
收藏本站
网站地图
|
English
|
公务邮箱
About the library
Background
History
Leadership
Organization
Readers' Guide
Opening Hours
Collections
Help Via Email
Publications
Electronic Information Resources
常用资源
电子图书
期刊论文
学位会议
外文资源
特色专题
内部出版物
Wiley电子期刊(2)
SpringerLink电子期刊(14)
Elsevier电子期刊(25)
在“
Elsevier电子期刊
”中,
命中:
25
条,耗时:小于0.01 秒
在所有数据库中总计命中:
41
条
1.
Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)
作者:
Andrea Necchi
a
;
andrea.necchi@istitutotumori.mi.it
;
Guru Sonpavde
b
;
Salvatore Lo Vullo
a
;
Daniele Giardiello
a
;
Aristotelis Bamias
c
;
Simon J. Crabb
d
;
Lauren C. Harshman
e
;
Joaquim Bellmunt
e
;
Ugo De Giorgi
f
;
Cora N. Sternberg
g
;
Linda Cerbone
g
;
Sylvain Ladoire
h
;
Yu-Ning Wong
i
;
Evan Y. Yu
j
;
Simon Chowdhury
k
;
Gunter Niegisch
l
;
Sandy Srinivas
m
;
Ulka
N.
Vaishampayan
n
;
Sumanta K. Pal
o
;
Neeraj Agarwal
p
;
Ajjai Alva
q
;
Jack Baniel
r
;
Ali-Reza Golshayan
s
;
Rafael Morales-Barrera
t
;
Daniel W. Bowles
u
;
Matthew I. Milowsky
v
;
Christine Theodore
w
;
Dominik R. Berthold
x
;
Gedske Daugaard
y
;
Srikala S. Sridhar
z
;
Thomas Powles
aa
;
Jonathan E. Rosenberg
bb
;
Matthew D. Galsky
cc
;
Luigi Mariani
a
;
RISC Investigators
关键词:
Urothelial carcinoma
;
Overall survival
;
Prognosis
;
Platinum chemotherapy
;
Nomogram
刊名:European Urology
出版年:2017
2.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
作者:
Dr Arjun V Balar
;
MD
a
;
arjun.balar@nyumc.org
;
Matthew D Galsky
;
MD
b
;
Jonathan E Rosenberg
;
MD
c
;
Thomas Powles
;
MD
d
;
Daniel P Petrylak
;
MD
e
;
Joaquim Bellmunt
;
MD
f
;
Yohann Loriot
;
MD
g
;
Andrea Necchi
;
MD
h
;
Jean Hoffman-Censits
;
MD
i
;
Jose Luis Perez-Gracia
;
MD
j
;
Nancy A Dawson
;
MD
k
;
Michiel S van der Heijden
;
MD
l
;
Robert Dreicer
;
MD
m
;
Sandy Srinivas
;
MD
n
;
Margitta M Retz
;
MD
o
;
Richard W Joseph
;
MD
p
;
Alexandra Drakaki
;
MD
q
;
Ulka
N
Vaishampayan
;
MD
r
;
Srikala S Sridhar
;
MD
s
;
David I Quinn
;
MD
t
;
Ignacio Durá
n ;
MD
u
;
David R Shaffer
;
MD
v
;
Bernhard J Eigl
;
MD
w
;
Petros D Grivas
;
MD
x
;
Evan Y Yu
;
MD
y
;
Shi Li
;
PhD
z
;
Edward E Kadel III
;
BS
z
;
Zachary Boyd
;
MSc
z
;
Richard Bourgon
;
PhD
z
;
Priti S Hegde
;
PhD
z
;
Sanjeev Mariathasan
;
PhD
z
;
AnnChristine Thå
;
strö
m ;
PhD
z
;
Oyewale O Abidoye
;
MD
z
;
Gregg D Fine
;
MD
z
;
Dean F Bajorin
;
MD
c
;
for the IMvigor210 Study Group
&dagger
;
刊名:The Lancet
出版年:2017
3.
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
作者:
Dr Andrew J Armstrong
;
MD
a
;
andrew.armstrong@duke.edu" class="auth_mail" title="E-mail the corresponding author
;
Prof Susan Halabi
;
PhD
a
;
Prof Tim Eisen
;
MD
b
;
Samuel Broderick
;
MS
c
;
Prof Walter M Stadler
;
MD
d
;
Prof Robert J Jones
;
MD
e
;
Jorge A Garcia
;
MD
f
;
Prof
Ulka
N
Vaishampayan
;
MD
g
;
Prof Joel Picus
;
MD
h
;
Prof Robert E Hawkins
;
MD
i
;
Prof John D Hainsworth
;
MD
j
;
Prof Christian K Kollmannsberger
;
MD
k
;
Prof Theodore F Logan
;
MD
l
;
Igor Puzanov
;
MD
m
;
Lisa M Pickering
;
MD
n
;
Christopher W Ryan
;
MD
o
;
Andrew Protheroe
;
MD
p
;
Christine M Lusk
;
MPH
q
;
Sadie Oberg
;
BS
q
;
Prof Daniel J George
;
MD
a
刊名:The Lancet Oncology
出版年:2016
4.
Phase II Trial of Carboplatin, Everolimus, and Prednisone in Metastatic Castration-resistant Prostate Cancer Pretreated With Docetaxel Chemotherapy: A Prostate Cancer Clinical Trial Consortium Study
作者:
Ulka
Vaishampayan
a
;
vaishamu@karmanos.org" class="auth_mail" title="E-mail the corresponding author
;
Daniel Shevrin
b
;
Mark Stein
c
;
Lance Heilbrun
d
;
Susan Land
e
;
Karri Stark
a
;
Jing Li
a
;
Brenda Dickow
a
;
Elisabeth Heath
a
;
Daryn Smith
d
;
Joseph Fontana
e
刊名:Urology
出版年:2015
5.
Phase II trial of bevacizumab and satraplatin in docetaxel-pretreated metastatic castrate-resistant prostate cancer
作者:
Ulka
N.
Vaishampayan
;
Joseph Fontana
;
Lance K. Heilbrun
;
Daryn Smith
;
Elisabeth Heath
;
Brenda Dickow
;
William D. Figg
关键词:
Excision repair polymorphism
;
Prostate cancer
;
Chemotherapy
;
Phase II clinical trial
刊名:Urologic Oncology: Seminars and Original Investigations
出版年:January, 2014
6.
Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy
作者:
Rana R. McKay
;
Nils Kroeger
;
Wanling Xie
;
Jae-Lyun Lee
;
Jennifer J. Knox
;
Georg A. Bjarnason
;
Mary J. MacKenzie
;
Lori Wood
;
S
;
y Srinivas
;
Ulka
N.
Vaishampayan
;
Sun-Young Rha
;
Sumanta K. Pal
;
Frede Donskov
;
Srinivas K. Tantravahi
;
Brian I. Rini
;
Daniel Y.C. Heng
;
Toni K. Choueiri
关键词:
Bone metastases
;
Liver metastases
;
mTOR inhibitors
;
Outcome
;
Renal cell carcinoma
;
VEGF therapy
刊名:European Urology
出版年:March, 2014
7.
The Impact of Low Serum Sodium on Treatment Outcome of Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Cancer Database Consortium
作者:
Fabio A.B. Schutz
a
;
Wanling Xie
a
;
Frede Donskov
b
;
Monica Sircar
c
;
David F. McDermott
d
;
Brian I. Rini
e
;
Neeraj Agarwal
f
;
Sumanta Kumar Pal
g
;
Sandy Srinivas
h
;
Christian Kollmannsberger
i
;
Scott A. North
j
;
Lori A. Wood
k
;
Ulka
Vaishampayan
l
;
Min-Han Tan
m
;
Mary J. Mackenzie
n
;
Jae Lyun Lee
o
;
Sun-Young Rha
p
;
Takeshi Yuasa
q
;
Daniel Y.C. Heng
r
;
&dagger
;
;
Toni K. Choueiri
a
;
c
;
&dagger
;
;
toni_choueiri@dfci.harvard.edu" class="auth_mail
关键词:
Hyponatremia
;
Renal cell cancer
;
Anti-VEGF
;
Prognostic factors
刊名:European Urology
出版年:April, 2014
8.
The Effect of Targeted Therapy on Overall Survival in Advanced Renal Cancer: A Study of the National Surveillance Epidemiology and End Results Registry Database
作者:
Ulka
Vaishampayan
;
vaishamu@karmanos.org" class="auth_mail
;
Hema Vankayala
;
Fawn D. Vigneau
;
William Quarshie
;
Brenda Dickow
;
Supraja Chalasani
;
Kendra Schwartz
关键词:
Kidney cancer
;
Nephrectomy
;
Outcomes
;
Racial disparity
;
SEER database
刊名:Clinical Genitourinary Cancer
出版年:April, 2014
9.
Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials
作者:
Guru Sonpavde
a
;
&dagger
;
;
Gregory R. Pond
b
;
&dagger
;
;
Ronan Fougeray
c
;
&dagger
;
;
Toni K. Choueiri
d
;
&dagger
;
;
Angela Q. Qu
d
;
David J. Vaughn
e
;
Guenter Niegisch
f
;
Peter Albers
f
;
Nicholas D. James
g
;
Yu-Ning Wong
h
;
Yoo-Joung Ko
i
;
Srikala S. Sridhar
j
;
Matthew D. Galsky
k
;
Daniel P. Petrylak
l
;
Ulka
N.
Vaishampayan
m
;
Awais Khan
a
;
Nicholas J. Vogelzang
n
;
Tomasz M. Beer
o
;
Walter M. Stadler
p
;
Peter H. O&rsquo
;
Donnell
p
;
Cora N. Sternberg
q
;
Jonathan E. Rosenberg
r
;
Joaquim Bellmunt
s
;
joaquim.bellmunt@gmail.com
关键词:
Urothelial carcinoma
;
Second line
;
Prognosis
;
Time from prior chemotherapy
;
Hemoglobin
;
Liver metastasis
;
Performance status
刊名:European Urology
出版年:2013
10.
A Phase II Safety and Efficacy Study of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Patients With Metastatic Urothelial Cancer
作者:
Roberto Pili
;
Rui Qin
;
P.J. Flynn
;
Joel Picus
;
Michael Millward
;
Wing Ming Ho
;
Henry Pitot
;
Winston Tan
;
Kiersten M. Miles
;
Charles Erlichman
;
Ulka
Vaishampayan
关键词:
Pazopanib
;
Urothelial cancer
;
VEGF tyrosine kinase inhibitors
刊名:Clinical Genitourinary Cancer
出版年:December, 2013
1
2
3
按检索点细分(25)
作者(25)
按出版年细分(25)
2027年及以后(5)
2017年(2)
2016年(1)
2015年(1)
2013年(2)
2012年(2)
2011年(1)
2010年(1)
2009年(1)
2008年(2)
2006年(1)
2005年(1)
2004年(2)
2002年(1)
2000年及以前(2)
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via
email
.